Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what representations (a) he and (b) his officials are making to counterparts in France on allowing British travellers arriving in France who have received the AstraZeneca/Oxford covid-19 vaccines sourced from the Serum Institute of India to follow regulations in France in-line with people who are fully vaccinated with other approved covid-19 vaccines.

The Government is in close touch with partners across Europe, including France, on the issue of the 5 million doses of AstraZeneca that were manufactured by the Serum Institute of India for use in the UK, called Vaxzevria. The European Medicines Agency has authorised this vaccine and we are confident travel will not be affected. The Government stands ready to share further details of the MHRA's approval of this particular batch should it be required.